This HTML5 document contains 140 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35601661
rdf:type
wikibase:Item
schema:description
2003年论文 научна статия teaduslik artikkel scienca artikolo artigo científico articolo scientifico наукова стаття, опублікована в серпні 2003 article científic 2003年论文 2003年论文 artículu científicu espublizáu en 2003 мақолаи илмӣ wetenschappelijk artikel επιστημονικό άρθρο vědecký článek 2003年论文 wissenschaftlicher Artikel 2003 nî lūn-bûn artikulong pang-agham bài báo khoa học article scientifique 2003年論文 scientific article published on August 2003 artigo científico vitenskapelig artikkel 2003年论文 2003年論文 2003年論文 บทความทางวิทยาศาสตร์ מאמר מדעי научни чланак სამეცნიერო სტატია vedecký článok articol științific vetenskaplig artikel artykuł naukowy 2003年论文 مقالة علمية نشرت في أغسطس 2003 artikull shkencor 2003年論文 научная статья 2003年論文 2003년 논문 tieteellinen artikkeli videnskabelig artikel vitskapeleg artikkel scientific article published on August 2003 2003年の論文 artigo científico artículo científico publicado en 2003 научни чланак naučni članak bilimsel makale artikel ilmiah scientific article published on August 2003 আগস্ট ২০০৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ article scientific tudományos cikk
p:P577
wds:Q35601661-0DDAA8FD-45BC-4292-8FAB-9A360264E310
wdt:P577
2003-08-01T00:00:00Z
p:P2860
wds:Q35601661-06C97C21-71F4-4B90-B4CE-27F6D1B9EF70 wds:Q35601661-0EE7B4AB-08E6-42A1-A9BE-BC57B0A7F01F wds:Q35601661-789B035E-94A8-407E-BBE7-87FB5239D7D1 wds:Q35601661-7FEB4F19-98BC-4407-A9E0-D1BBA2B72883 wds:Q35601661-81AA767C-FB4C-45B2-92C1-045EBF8173FE wds:Q35601661-9277F950-1125-4161-895D-200FCB351494 wds:Q35601661-5FDB9B12-42A7-4497-A2FB-2B7B38DD7260 wds:Q35601661-6EA569D6-49B8-48CE-8E3B-5AC52A1D5D27 wds:Q35601661-72E51A57-7884-4B5A-B192-8713F4C06F1B wds:Q35601661-75C4604E-64C9-4124-8F8F-BD2CADEE9E2F wds:Q35601661-31CE57E8-D759-418A-BAE5-3D4DFE064EA0 wds:Q35601661-5309B514-1540-45AD-8D81-77B9873D8B60 wds:Q35601661-58C523B6-5932-4393-AF39-76ED46AFAD73 wds:Q35601661-22179401-696B-4613-B355-C6E05C2DC199 wds:Q35601661-22EE9B3F-14A6-48FE-A2E4-FE7751A881DB wds:Q35601661-D8385F08-22E7-45CB-9D4A-EC1351D1405C wds:Q35601661-E42F6324-9DAB-446A-AF27-AF87B5B2337C wds:Q35601661-C893ED21-2317-4E88-AA97-FFF15618D63C wds:Q35601661-CBC7D68A-24AB-4F3C-B020-5649E14B66D7 wds:Q35601661-D0FD0028-48F3-4910-8132-7DFA0D506164 wds:Q35601661-A62488C6-4240-44A9-8DD5-A0ABD934F6BF wds:Q35601661-B7C7968F-D889-4B9B-AD33-D1D4C4A74C7F wds:Q35601661-BA191ACA-0CD1-4AC8-AD2A-D651C7B1DFEF wds:Q35601661-A199FA0C-EF23-4449-B824-DE08F00BD5AF
wdt:P2860
wd:Q74344629 wd:Q34324255 wd:Q36641310 wd:Q43601697 wd:Q32034470 wd:Q33970570 wd:Q34782022 wd:Q34985245 wd:Q34247917 wd:Q58211015 wd:Q42283820 wd:Q37360238 wd:Q40770115 wd:Q35004491 wd:Q40840471 wd:Q36116374 wd:Q34152748 wd:Q73504275 wd:Q39946675 wd:Q34756716 wd:Q39946634 wd:Q74593419 wd:Q71890854 wd:Q77669938
p:P2093
wds:Q35601661-E7462C85-26C5-4ECF-B201-964664146ADB
wdt:P2093
Jean-Jacques Body
rdfs:label
Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions
skos:prefLabel
Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions
schema:name
Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions
p:P1476
wds:Q35601661-20DF68E8-2D34-4967-B2F4-D7CB9A8B9C70
wdt:P1476
Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions
p:P304
wds:Q35601661-D3C6EA5D-2BC8-4D22-BF56-A8F2B6FA9139
wdt:P304
S37-44
p:P31
wds:Q35601661-9e64b410-33de-44c2-99fa-ec0ae58c4485 wds:Q35601661-977D64D2-604E-4955-8D4D-B05F9BB76D39
wdt:P31
wd:Q7318358 wd:Q13442814
p:P921
wds:Q35601661-452C63DA-5BDA-4185-8C19-C3ECD7E4F93C
wdt:P921
wd:Q2035084
p:P698
wds:Q35601661-95507C6C-23AE-49F7-A20D-78008399AC90
wdtn:P698
n8:14659142
wdt:P698
14659142
p:P1433
wds:Q35601661-1F04AE3C-58BA-401C-A1E7-F718A46C1526
wdt:P1433
wd:Q7719928
p:P478
wds:Q35601661-225A7377-E2C9-4E3B-949E-E0BD632B43EB
wdt:P478
12 Suppl 2
p:P356
wds:Q35601661-B194924C-47F0-4C76-949B-A5D7C32F15D0
wdtn:P356
n12:S0960-9776(03)80162-5
wdt:P356
10.1016/S0960-9776(03)80162-5